RECIP 1.0: A Roadmap for Clinical Implementation

Objective response evaluation in oncologic disease is a key endpoint of patient outcome. Response assessment has been performed using tumor measurements at the individual lesion level. For example, RECIST 1.1 defines progression on CT images on the basis of a change in lesion diameter or occurrence